Migraine (28263)

COR Clinical Research is evaluating an investigational medication for patients with moderate to severe migraine headaches. Patients that qualify will receive study related medical care, study medication, and migraine education at no charge. Study duration is 12 weeks and would require 3-4 visits. Study will also have optional additional (extension) of 26-58 weeks depending on severity of migraines.

Entry Qualifications:

1. *  Have moderate to severe migraine headaches that last between 4 - 72 hours.
2. *  Have no more than 8 migraine headaches a month.
3. *  Between the ages of 18 - 65.
4. *  Can have asthma

If you would like more information, or are interested in participating in this study please contact COR Clinical Research at (405) 272-8481 and mention grant #28263.